TOPICA Pharmaceuticals Receives $27,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=046adf38-c4aa-4265-a07f-0772c1d16358&Preview=1 -
Date
10/18/2011 -
Company Name
TOPICA Pharmaceuticals -
Mailing Address
435 Tasso Street Palo Alto, CA 94301 -
Company Description
Topica Pharmaceuticals, Inc. is a privately held, clinical-stage specialty pharmaceutical company focused exclusively on developing the first highly effective, safe and convenient topical treatment for onychomycosis, or fungal infections of the toenail and nail bed. -
Website
http://www.topicapharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$27,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The Series B round will be used for continued development of the company’s broad-spectrum topical antifungal agent. -
M&A Terms
-
Venture Investor
Third Rock Ventures -
Venture Investor
Prospect Venture Partners -
Venture Investor
Yasuda Enterprise Development
